Sced Medical Services Limited 11111198 false 2023-01-01 2023-12-31 2023-12-31 The principal activity of the company is that of specialist medical activities. Digita Accounts Production Advanced 6.30.9574.0 true true 11111198 2023-01-01 2023-12-31 11111198 2023-12-31 11111198 bus:Director1 1 2023-12-31 11111198 bus:OrdinaryShareClass1 2023-12-31 11111198 bus:OrdinaryShareClass2 2023-12-31 11111198 bus:OrdinaryShareClass3 2023-12-31 11111198 bus:OrdinaryShareClass4 2023-12-31 11111198 bus:OrdinaryShareClass5 2023-12-31 11111198 core:RetainedEarningsAccumulatedLosses 2023-12-31 11111198 core:ShareCapital 2023-12-31 11111198 core:CurrentFinancialInstruments 2023-12-31 11111198 core:CurrentFinancialInstruments core:WithinOneYear 2023-12-31 11111198 core:OfficeEquipment 2023-12-31 11111198 bus:SmallEntities 2023-01-01 2023-12-31 11111198 bus:AuditExemptWithAccountantsReport 2023-01-01 2023-12-31 11111198 bus:FilletedAccounts 2023-01-01 2023-12-31 11111198 bus:SmallCompaniesRegimeForAccounts 2023-01-01 2023-12-31 11111198 bus:RegisteredOffice 2023-01-01 2023-12-31 11111198 bus:Director1 2023-01-01 2023-12-31 11111198 bus:Director1 1 2023-01-01 2023-12-31 11111198 bus:OrdinaryShareClass1 2023-01-01 2023-12-31 11111198 bus:OrdinaryShareClass2 2023-01-01 2023-12-31 11111198 bus:OrdinaryShareClass3 2023-01-01 2023-12-31 11111198 bus:OrdinaryShareClass4 2023-01-01 2023-12-31 11111198 bus:OrdinaryShareClass5 2023-01-01 2023-12-31 11111198 bus:PrivateLimitedCompanyLtd 2023-01-01 2023-12-31 11111198 bus:Agent1 2023-01-01 2023-12-31 11111198 core:OfficeEquipment 2023-01-01 2023-12-31 11111198 countries:England 2023-01-01 2023-12-31 11111198 2022-12-31 11111198 bus:Director1 1 2022-12-31 11111198 core:OfficeEquipment 2022-12-31 11111198 2022-01-01 2022-12-31 11111198 2022-12-31 11111198 bus:Director1 1 2022-12-31 11111198 bus:OrdinaryShareClass1 2022-12-31 11111198 bus:OrdinaryShareClass2 2022-12-31 11111198 bus:OrdinaryShareClass3 2022-12-31 11111198 bus:OrdinaryShareClass4 2022-12-31 11111198 bus:OrdinaryShareClass5 2022-12-31 11111198 core:RetainedEarningsAccumulatedLosses 2022-12-31 11111198 core:ShareCapital 2022-12-31 11111198 core:CurrentFinancialInstruments 2022-12-31 11111198 core:CurrentFinancialInstruments core:WithinOneYear 2022-12-31 11111198 core:OfficeEquipment 2022-12-31 11111198 bus:Director1 1 2022-01-01 2022-12-31 11111198 bus:Director1 1 2021-12-31 iso4217:GBP xbrli:pure xbrli:shares

Registration number: 11111198

Sced Medical Services Limited

Unaudited Filleted Financial Statements

for the Year Ended 31 December 2023

 

Sced Medical Services Limited

Contents

Company Information

1

Director's Report

2

Accountants' Report

3

Balance Sheet

4 to 5

Notes to the Unaudited Financial Statements

6 to 10

 

Sced Medical Services Limited

Company Information

Director

Dr AM Sced

Registered office

Wellesley House
204 London Road
Waterlooville
Hampshire
PO7 7AN

Accountants

MMO Limited
Wellesley House
204 London Road
Waterlooville
Hampshire
PO7 7AN

 

Sced Medical Services Limited

Director's Report for the Year Ended 31 December 2023

The director presents her report and the financial statements for the year ended 31 December 2023.

Director of the company

The director who held office during the year was as follows:

Dr AM Sced

Principal activity

The principal activity of the company is that of specialist medical activities.

Small companies provision statement

This report has been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

Approved and authorised by the director on 6 August 2024
 

.........................................
Dr AM Sced
Director

 

Chartered Accountants' Report to the Director on the Preparation of the Unaudited Statutory Accounts of
Sced Medical Services Limited
for the Year Ended 31 December 2023

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the accounts of Sced Medical Services Limited for the year ended 31 December 2023 as set out on pages 4 to 10 from the company's accounting records and from information and explanations you have given us.

As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed at
http://www.icaew.com/regulation.

This report is made solely to the Board of Directors of Sced Medical Services Limited, as a body, in accordance with the terms of our engagement letter. Our work has been undertaken solely to prepare for your approval the accounts of Sced Medical Services Limited and state those matters that we have agreed to state to the Board of Directors of Sced Medical Services Limited, as a body, in this report in accordance with ICAEW Technical Release 07/16 AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Sced Medical Services Limited and its Board of Directors as a body for our work or for this report.

It is your duty to ensure that Sced Medical Services Limited has kept adequate accounting records and to prepare statutory accounts that give a true and fair view of the assets, liabilities, financial position and profit of Sced Medical Services Limited. You consider that Sced Medical Services Limited is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or a review of the accounts of Sced Medical Services Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory accounts.

......................................

MMO Limited
Wellesley House
204 London Road
Waterlooville
Hampshire
PO7 7AN

23 September 2024

 

Sced Medical Services Limited

(Registration number: 11111198)
Balance Sheet as at 31 December 2023

Note

2023
£

2022
£

Fixed assets

 

Tangible assets

4

979

1,305

Current assets

 

Debtors

5

49,551

28,157

Cash at bank and in hand

 

125,453

104,864

 

175,004

133,021

Creditors: Amounts falling due within one year

6

(20,723)

(16,790)

Net current assets

 

154,281

116,231

Total assets less current liabilities

 

155,260

117,536

Provisions for liabilities

(245)

(248)

Net assets

 

155,015

117,288

Capital and reserves

 

Called up share capital

7

140

140

Retained earnings

154,875

117,148

Shareholders' funds

 

155,015

117,288

For the financial year ending 31 December 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the director has not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the director on 6 August 2024
 

 

Sced Medical Services Limited

(Registration number: 11111198)
Balance Sheet as at 31 December 2023

.........................................
Dr AM Sced
Director

 

Sced Medical Services Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2023

1

General information

The company is a private company limited by share capital, incorporated in England.

The address of its registered office is:
Wellesley House
204 London Road
Waterlooville
Hampshire
PO7 7AN
England

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

All figures are presented in British Sterling, which is the functional currency of the company, and are rounded to the nearest £1.

Going concern

The financial statements have been prepared on a going concern basis.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tax

The tax expense for the period comprises current and deferred tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

 

Sced Medical Services Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2023

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Deferred tax is recognised in respect of all timing differences between taxable profits and profits reported in the financial statements.

Unrelieved tax losses and other deferred tax assets are recognised when it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Office equipment

25% - written down value

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

 

Sced Medical Services Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2023

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Dividends

Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

3

Staff numbers

The average number of persons employed by the company (including the director) during the year, was 1 (2022 - 1).

4

Tangible assets

Office equipment
£

Total
£

Cost or valuation

At 1 January 2023

2,427

2,427

At 31 December 2023

2,427

2,427

Depreciation

At 1 January 2023

1,122

1,122

Charge for the year

326

326

At 31 December 2023

1,448

1,448

Carrying amount

At 31 December 2023

979

979

At 31 December 2022

1,305

1,305

 

Sced Medical Services Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2023

5

Debtors

Current

2023
£

2022
£

Trade debtors

29,524

28,157

Other debtors

20,027

-

 

49,551

28,157

6

Creditors

Creditors: amounts falling due within one year

2023
£

2022
£

Due within one year

Taxation and social security

19,505

15,226

Accruals and deferred income

1,218

1,218

Other creditors

-

346

20,723

16,790

7

Share capital

Allotted, called up and fully paid shares

2023

2022

No.

£

No.

£

Ordinary shares of £1 each

100

100

100

100

Ordinary A shares of £1 each

10

10

10

10

Ordinary B shares of £1 each

10

10

10

10

Ordinary C shares of £1 each

10

10

10

10

Ordinary D shares of £1 each

10

10

10

10

140

140

140

140

 

Sced Medical Services Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2023

8

Related party transactions

Transactions with the director

2023

At 1 January 2023
£

Other payments made to company by director
£

At 31 December 2023
£

Dr AM Sced

The directors loan account balance is undated, unsecured, interest free and repayable on demand.

(345)

20,372

20,027

2022

At 1 January 2022
£

Advances to director
£

At 31 December 2022
£

Dr AM Sced

The directors loan account balance is undated, unsecured, interest free and repayable on demand.

(24,363)

24,018

(345)